. The regularity and precise termination ofthe perineal raphe Figure 1 illustrates the hypertrophied raphe as it was seen in the first and second infants. The third case in the prematurely born twin with birthweight of 780 g was compared with his twin's perineal raphe and, whereas the raphe in the affected twin was of the calibre of the lead in a pencil, that of the unaffected was of the calibre of a hog's bristle.
Discussion
The urethral folds appear at the undifferentiated stage in the development of the external genitalia and they include the cloacal membrane. The fusion of the urethral folds from Journal of the Royal Society of Medicine Volume 84 December 1991 751 the posterior or cloacal end forwards traverses the embryonal region, then the eventual scrotal midline to reach its termination at the distal end of the penis. The perineal, scrotal and penile raphes constitute, therefore, one continuous raphe.
A feature of the hypertrophied perineal raphe in the three infants observed was the precise anterior termination of the hypertrophy of the perineal raphe at the perineoscrotal junctionthe scrotal and penile raphes being completely unaffected. The posterior termination, however, was visibly imprecise in that the raphe crossed the anterior border of the anus where it dipped into the anal canal ( Figure 1 ).
A search in the medical literature has discovered no comparable case. Recently a 'prominent perineal raphe' was added to Townes-Brocks syndrome's rather large collection'. The raphe added, however, was not a simple regular hypertrophy, as illustrated here, but more in the nature of irregular coarse enlargement. The Townes-Brocks syndrome necessarily includes inherited familial association and such relationship is surely excluded from the three cases recorded here, which is emphasized by the fact that one case was a dissimilar twin. In the case illustrated here it was the mother herself who first noticed the hypertrophy for which she sought medical opinion; and in all three cases there was no other defect of surface anatomy. Hereditary protein C deficiency is inherited as an autosomal dominant trait and is a risk factor for venous thrombosis'<, We present a patient with portal vein thrombosis and oesophageal varices associated with protein C deficiency who also had tuberous sclerosis and a retroperitoneal angioleiomyoma.
Case report
A 51-year-old Caucasian woman presented with a haema. temasis. She was known to have tuberous sclerosis (without a family history) and a few years previously she had a segmental small bowel resection for mesenteric venous infarction.
On examination she was ofnormal intelligence and the only significant findings were adenoma sebaceum, moderate hepatosplenomegaly and an ill-defined mass in the right abdominal flank.
Upper gastrointestinal endoscopy demonstrated three large columns of oesophageal varices which were injected with ethanolamine oleate. Further investigations included Correspondence to: Dr I M Murray-Lyon abdominal ultrasound which showed moderate hepatosplenomegaly, portal vein thrombosis and a right-sided retroperitoneal mass. Coeliac and mesenteric angiography demonstrated portal vein occlusion. CT scan of the abdomen confirmed the retroperitoneal mass pushing forward the kidney. Needle biopsy showed this to be a benign angioleiomyoma.
Further investigations performed to identify any underlying thrombotic state, included platelet aggregation, fibrinogen level, tests of fibrinolytic activity, Ham's test, lupus anticoagulant tests and cardiolipin antibody and levels of antithrombin Ill, protein C and protein S. The only abnormality was a low level of protein C: activity 53% (normal range 75-120) antigen 57% (normal range 70-140).
The low levels of protein C in conjunction with normal liver function tests and normal levels of protein S were consistent with a diagnosis of heterozygous type 1 protein C deficiency. As anticoagulation was contra-indicated by the large oesophageal varices, she was treated initially with danazol and one month later protein C levels had risen to normal (activity 117%, antigen 102%). However, she subsequently developed extensive deep venous thrombosis in her right leg. As the varices had now been obliterated by sclerotherapy, she was anticoagulated and is currently maintained on warfarin.
Discussion
Protein C is a potent thrombin-dependent anticoagulant enzyme whose function is to inactivate coagulation cofactors V and VIII and to stimulate fibrinolysis 1. It is synthesized by the liver and is vitamin K dependent. Most individuals with an inherited defect have levels of protein C of around 50% of normal values, consistent with the heterozygous state 1 ,2. It has been estimated that protein C deficiency accounts for 5-8% of unexplained venous thrombosis in young individuals'', The clinical manifestations of protein S deficiency are similar. Superficial thrombophlebitis occurs in approximately 70% of patients with protein S or C deficiency":", deep venous thrombosis in 75% and recurrent pulmonary embolism in 30%3. Mesenteric and portal vein thrombosis which both occurred in this case are less common'':".
It is well recognized that there is an association between tuberous sclerosis and retroperitoneal angioleiomyoma. There does not appear to be an established link between tuberous sclerosis and protein C deficiency. The former is linked to markers on chromosome 9, whereas the gene for protein C has been isolated and assigned to chromosome 2 s.
The clinical response chosen for the combination of bleeding oesophages varices and a hypercoagulable state was to aim to obliterate the varices by injection sclerotherapy and then to maintain anticoagulation with warfarin. The use of danazol as an interim measure until anticoagulation could be safely undertaken was based on the evidence that anabolic steroids increase protein C levels". However, this treatment may not offer effective protection against thrombosis as illustrated by the development of further thrombotic problems in our case. Cyclical hypothermia is an uncommon manifestation of hypothalamic dysfunction. The only effective therapeutic agent is naloxone'<. Bromocriptine, haloperidol, cyproheptadine', dexamphetamine", anti-epileptic drugs l .3,4 and thyroid hormonesv':" are ineffective. We report the successful use of ephedrine.
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Case report
An 18-year-old woman with hypogonadotrophic hypogonadism was repeatedly admitted in hypothermic coma (core temperature 32.0-33.5°C). Aged 14 years she was treated with thyroxine because of symptoms of lethargy and slow activity with a normal T 3 and T 4 but an elevated thyroid-stimulating hormone (TSH) of 20.7(O.3-6.0)mUIl. Prolactin was 848 mUll without other pituitary/hypothalamic biochemical abnormality and an MRI scan was normal.
When hypothermic, her skin temperature was only I-3°C below core temperature. She had no sense of thermal discomfort and normal thermal sensory thresholds". During rewarming her core temperature did not exceed 35.6°C excluding poikiliothermia.
After one hour's acclimatization in a temperature controlled laboratory at 22±0.5°C, the laboratory was Haemostasis 1987; 57:20-4 (Accepted 3 January 1991) cooled by 4°C for 30 min. Core (tympanic membrane) and skin (great toe pulp) temperature was measured. Thermoregulatory blood flow in the great toe pulp was assessed by laser Doppler flowmetry (Periflux Pf1 Perimed Sweden). Her peripheral skin temperature and blood flow were inappropriately high after cooling when compared to an age/sex matched control (Figure 1 ). There was no response to naloxone-". When taking ephedrine 30 mg four times daily her core temperature increased and there was partial peripheral vasoconstriction, maximal 2 h after a dose (Figure 1 ). She took ephedrine 30 mg four times daily for two 14-day periods at home. Her meantso) oral temperature, compared with the preceding fortnight, increased from 34.6(0.56)OC to 35.6(0.73)OC in the morning, and from 33.9(0.41)OC to 34.9(0.42)OC in the evening. She avoided readmission with hypothermia by taking ephedrine 30 mg four times daily for a week whenever her oral temperature was below the critical value of 34°C at which she became functionally impaired. Thyroxine was withdrawn and her free T 4 and free T 3 remained normal. Her TSH rose to 26.7 mUll (alpha 
